BIRC5 and cancer: It was demonstrated that EV-bound Survivin (anti-apoptosis protein) was highly expressed in plasma collected from prostate [42] and breast [41] cancer patients compared to healthy persons, suggesting that EV-bound Survivin could serve as a potential diagnostic biomarker shared among multiple types of cancer.